Streptococcus pyogenes causes a spectrum of disease, ranging from pharyngitis to necrotizing soft tissue infections to toxic shock. Lethal necrotizing infections are characterized by an absence of neutrophils at the site of bacterial growth [1, 2] . Interleukin (IL)-8 (or CXCL8) is a major chemokine responsible for recruitment of neutrophils to sites of injury or infection. IL-8 is produced in interstitial tissues by epithelial cells, monocytes/mac-
rophages, and fibroblasts as a 72-residue polypeptide that passes from the abluminal to the luminal endothelial surface through interactions between heparan sulfates and the C-terminus of IL-8. IL-8 is presented to neutrophils on the luminal endothelial surface, is anchored by interactions between the C-terminus and glycosaminoglycans, and can induce neutrophil slowing and arrest, which are essential for subsequent neutrophil transmigration [3] . IL-8 activates neutrophils through interaction with the 7 transmembrane domain-spanning CXCR1 or CXCR2 cell surface receptor. The complex nature of the CXCRs has hindered full analysis of receptor-ligand interactions, although the IL-8 N-terminus seems to be important [4, 5] .
Although several purified S. pyogenes products stimulate production of IL-8 by mononuclear cells [6] , IL-8 production is remarkably poor when cells are stimulated with whole S. pyogenes supernatants [7] . Here, we demonstrate that IL-8 is inactivated by S. pyogenes supernatants and demonstrate that inactivation occurs through a specific cleavage at the C-terminus between positions 59 Q and 60 This represents a novel and highly specific mechanism by which S. pyogenes can combat the innate immune response to infection.
MATERIALS AND METHODS
Reagents and ELISA. Carrier-free recombinant human IL-8, murine macrophage inflammatory protein (MIP)-2, and other cytokines were obtained from R&D Systems. Recombinant human C5a was obtained from Calbiochem. Monoclonal and polyclonal biotinylated antibodies to human IL-8 were obtained from R&D Systems and Biosource. Chemokines and cytokines were assayed by ELISA using paired antibodies in accordance with the manufacturer's protocols (R&D Systems). All samples were assayed in duplicate, and standards were diluted in buffers that were appropriate to test samples. Protease inhibitors were from Roche Diagnostics.
Bacterial supernatants. Blood and throat isolates of S. pyogenes were sequentially collected during November 1994-March 2000 at the Hammersmith Hospital, using a protocol that was approved by the local research ethics committee. Isolates were frozen as glycerol stocks and were passaged only once. Blood isolates were emm typed. Bacteria from single colonies were cultured in Todd Hewitt broth (TH; Oxoid) or RPMI 1640 with 10% fetal calf serum and 2 mmol/L glutamine (Life Technologies) for 18 h at 37ЊC without shaking. There was no difference in growth between blood isolates (median, 0.75 ϫ 10 8 [range, ] cfu/mL) and throat isolates 8 8 0.3 ϫ 10 -1.07 ϫ 10 (median, [range, ] cfu/mL). 1.07 ϫ 10 0.41 ϫ 10 -1.48 ϫ 10 Cell-free supernatants were obtained by centrifugation (at 800 g) and filtration using 0.2 mmol/L filters (Sartorius AG).
IL-8 degradation. To compare isolates, S. pyogenes-TH supernatants (1:50 dilution) were incubated with 2 ng/mL IL-8 for 18 h at 37ЊC. S. pyogenes strain H292-TH supernatant (1: 50) was incubated with 1 ng/mL IL-8 for 2, 4, 6, 8, and 24 h at 37ЊC, before measurement of residual IL-8 by ELISA. Degrading activity was expressed as nanograms of IL-8 digested per hour per microliter of H292 supernatant. For in vitro experiments using human neutrophils, IL-8 was cleaved with H292-RMPI supernatant (1:50). For some experiments, IL-8 was incubated with a purified H292 enzyme preparation (described below).
SDS-PAGE and Western blotting. Proteins were separated by SDS-PAGE using 17.5% (for chemokines) or 10% gels and were stained with either silver or Coomassie blue. Separated proteins were immunoblotted using biotinylated anti-IL-8 antibodies and streptavidin-conjugated horseradish peroxidase and were visualized with the ECL system (Amersham Pharmacia Biotech).
Peptide and protein identification. Protein identification was performed after reduction, carbamidomethylation, and digestion with trypsin. Peptides were separated on a Waters CapLC chromatograph using an LC Packings Nan 75-15-OS-C18-PM column eluting at 200 nL/min with a linear gradient of acetonitrile:water:formic acid (5:95:0.1 to 95:5:0.1). During liquid chromatography (LC), the flow was directed into the positive ion nanospray ion source of a Waters QtoF-2 mass spectrometer operated in the survey mode. Proteins were identified using the Mascot search engine (Matrix Science) [8] . IL-8, MIP-2, C5a, and fragments were chromatographed on a 5-mm Vydac C4MS column ( mm) eluting at 5 mL/min with a 30-min linear 0.3 ϫ 5 gradient of acetonitrile:water:formic acid (5:95:0.1 to 60:40: 0.1). The LC flow was directed into the nanospray source of the QtoF-2 mass spectrometer for analysis by positive ion electrospray ionization mass spectrometry (ESI-MS).
Neutrophil response to cleaved IL-8. IL-8 was cleaved with 1:50 H292-RPMI supernatant overnight at 37ЊC; cleavage was confirmed by SDS-PAGE. The controls were IL-8 and H292-RPMI supernatant alone. Purified H292 enzyme preparation was used for in vivo studies. Neutrophils were purified from peripheral blood of volunteers by Percoll density gradient centrifugation with dextran sedimentation and were resuspended at a density of cells/mL in RPMI 1640. Neutrophils (80 6 2 ϫ 10 mL) were coincubated for 30 min at 37ЊC with 80 mL of sample (IL-8, cleaved IL-8, or H292-RPMI supernatant) and then were stained with phycoerythrin-labeled anti-l-selectin (CD62L, clone Dreg 56; eBiosciences) or nonbinding isotype control murine IgG1 (eBiosciences). A FACScan flow cytometer (BD Biosciences) was used to collect 10,000 events/tube. Results were expressed as the change in mean fluorescence intensity (DMFI), compared with that in unstimulated cells. Control antibody binding was insignificant under all conditions. To examine migration across 5-mm transwells (Corning), neutrophils were incubated 6 1 ϫ 10 in the upper chamber, and 80 ng/mL IL-8 was placed in the lower 0.5-mL chamber; transmigrated neutrophils were counted after 2h, and the number was compared with the number in wells containing cleaved IL-8 or H292-RPMI supernatant. For examination of in vivo neutrophil migration, female C57BL/6 mice received intraperitoneally 300 mL of sterile saline containing either 1 mg of IL-8, 1 mg of cleaved IL-8, or 2 mL of diluted H292 purified enzyme preparation. Control mice received no stimulus. Mice were killed after 3 h, and peritoneal lavage was performed using 6 mL of saline containing 10% fetal calf serum and 10 U/ mL heparin. Total cell counts were performed on 500 mL of cells, and differential counts were performed by counting a minimum of 200 cells after cytospins and staining (Diff-Quik; Dade Behring). Mouse studies were performed in accordance with UK Home Office guidelines.
Characterization of IL-8 protease. H292-TH supernatant aliquots were removed at 45-min intervals after a 1% inoculation of broth and were incubated separately with 3 ng/mL IL-8; residual IL-8 was measured by ELISA. For initial size fractionation, H292-TH supernatants were centrifuged using Centricon 10-kDa, 30-kDa, 50-kDa, and 100-kDa filters (Mil- , unpaired t test) greater P p .001 degree of inactivation (as assessed by IL-8 ELISA) by blood isolates than by throat isolates. Strain H292 was among the most active against IL-8. Results are representative of repeat analyses performed using RPMI supernatants. B, Representative micrograph (objective magnification, ϫ40) of skeletal muscle collected from a patient infected with strain H292, causing necrotizing fasciitis. Note that although there are leukocytes in the venule lumen, they are not migrating through the endothelium into the tissue itself, despite the presence of obvious bacterial colonies. C, large colonies of streptococci; L, leukocytes in lumen; V, venule (vessel though which leukocytes migrate to tissue). Scale bar, 100 mm. lipore). IL-8 degradation was evaluated in the presence of 50 mg/mL antipain, 40 mg/mL bestatin, 30 mg/mL chymostatin, 10 mg/mL E64, 5 mg/mL leupeptin, 1 mg/mL pepstatin, 200 mg/mL phosphoromidon, 1 mg/mL Pefabloc, 1 mmol/L EDTA, 10 mg/ mL aprotonin, and 3 mmol/L phenylmethylsulfonyl fluoride (PMSF). H292 supernatant (1:5 dilution) was incubated with other cytokines (0.1 ng/mL and 1 ng/mL tumor necrosis factor [TNF]-a, IL-1b, interferon [IFN]-g, IL-6, or IL-8) in triplicate for 18 h at 37ЊC, and residual cytokines were measured by ELISA. In separate experiments, 25 pmol of IL-8, MIP-2, or C5a was incubated with 0.04-1 mg of the partially purified H292 enzyme preparation in 75 mL of ammonium bicarbonate (100 mmol/L; pH 7.5) for 1 or 18 h. Incubates were analyzed for degradation products by LC-MS.
Purification of IL-8 protease activity. Eleven liters of H292 was cultured in TH for 18 h at 37ЊC without shaking. Bacteria were removed by centrifugation, and the supernatant was passed through a 0.2 mmol/L filter. Proteins were precipitated at 4ЊC by incubation with 80% saturated ammonium sulfate. The precipitate was collected by centrifugation, resuspended in 600 mL of PBS, and concentrated by pressure filtration over a 30-kDa cutoff membrane (Sartorius) to a final volume of 75 mL. The concentrate (р10 mL) was applied at 2 mL/min to a Sephadex G75 column ( mm; Amersham Pharmacia 18 ϫ 300 Biotech) equilibrated in 20 mmol/L Tris-HCl (pH 9.0). Protein eluted in the void volume was collected, pooled, and concentrated over a 30-kDa cutoff membrane to a volume of 12 mL and then was subjected to anion exchange chromatography on a Q-fast flow column ( mm; Amersham Pharmacia 15 ϫ 100 Biotech) at 2 mL/min using a step gradient of increasing concentrations of NaCl (0, 0.1, 0.2, 0.3, 0.5, and 1.0 mol/L). Activity was expressed as nanograms of IL-8 digested per hour per microliter of enzyme preparation. Active fractions were pooled (50 mL) and concentrated to 1.5 mL, and volumes of 0.2 mL were subjected to gel filtration at 0.1 mL/min using a Superose 12 column collecting fractions of 0.5 mL. At each step, protease activity was measured by ELISA, and the complexity of the sample was determined by SDS-PAGE. Gel filtration fractions were then subjected to protein identification.
Antibody to S. pyogenes cell envelope proteinase (SpyCEP). The peptide FDPETNRFKPEPLKDRG, corresponding to residues 1028-1044 of the M1 SpyCEP sequence, was coupled to keyhole limpet hemocyanin at the N-terminus and polyclonal antibody raised in rabbits [9] . A total of 15 mL of 20ϫ concentrated supernatant from strains that exhibited the strongest (residual IL-8 concentration, !0.1 ng/mL) and the weakest (residual IL-8 concentration, 10.8 ng/mL) IL-8-degrading activity were separated by SDS-PAGE ( strains/group) and were n p 6 subjected to Western blotting using 1:500 diluted anti-SpyCEP and to development with ProteinG-peroxidase (Sigma) and the ECL system.
RESULTS
Degradation of IL-8 by invasive S. pyogenes isolates. S. pyogenes blood isolates were significantly better at inactivating IL-8 than were noninvasive throat isolates ( figure 1A) . One isolate, strain H292 (emm81), which was cultured from the blood and muscle of a patient who died of necrotizing fasciitis, was chosen for further study, because it was the most potent degrader. Histological examination of muscle sections from this patient revealed that, despite the presence of bacteria, there was limited evidence of neutrophil infiltration at the site of infection ( figure  1B) . Degradation of IL-8 could be detected after coincubation with H292-TH supernatant for 2 h and was complete by 8 h of coincubation, which corresponds to an IL-8 degradation rate of 0.01ng/h/mL of H292 supernatant. Degradation was specific for IL-8, because H292 supernatant had no detectable effect on the immunoreactivity of TNF-a, IL-1b, IFN-g, or IL-6 (data not shown).
IL-8 cleavage at the C-terminus. Analysis of IL-8 that was inactivated by H292-TH supernatant showed that the IL-8 band (mass, ∼8 kDa) disappeared, yielding a single cleavage product with a mass of ∼6 kDa (figure 2A). Cleaved IL-8 was recognized very weakly by polyclonal anti-IL-8 antibody (figure 2B) but not by any monoclonal antibody used. IL-8 was incubated with H292 purified enzyme preparation (see below), and the product, together with control IL-8, was subjected to high-performance liquid chromatography-MS analysis. IL-8 was eluted after 10.8 min of flow and generated an intense electrospray mass spectrum with multiply charged ions centered at massto-charge (m/z) ratios of 763.0, 839.2, 932.3, 1048.7, 1198.3, and 1397.7. Deconvoluting the spectra gave an average molecular weight (M Av ) of , which corresponds well to 8381.7 ‫ע‬ 0. Diminished biological activity of cleaved IL-8. IL-8 induced dose-dependent neutrophil CD62L (l-selectin) shedding, whereas cleaved IL-8 was unable to induce CD62L shedding at any concentration (figure 4A). Pefabloc was able to completely reverse the effects of H292-RPMI supernatant on IL-8-induced CD62L shedding (data not shown). The migration of human neutrophils in response to IL-8 was abrogated in response to cleaved IL-8 ( figure 4B ). H292-RPMI supernatant did not exert any nonspecific effect on neutrophil migration, because it did not inhibit neutrophil migration in response to C5a (data not shown). Injection of full-length IL-8 induced a significant increase in murine peritoneal neutrophils, compared with the number seen in controls, whereas cleaved IL-8 could not elicit a neutrophil response ( figure 4C ). Thus, inactivation of IL-8 by H292 resulted in a failure to recruit neutrophils and, in addition, reduced the activation status of the neutrophils.
Characterization of IL-8 protease. IL-8-degrading activity appeared in H292-TH supernatant at the start of exponential growth, was maximal by early-mid-log phase, and remained detectable throughout late log and stationary phase ( figure 5A ). IL-8-degrading activity was heat sensitive (30 min at 80ЊC) and was limited to fractions retained by a 1100-kDa filter. Activity was inhibited by the serine protease inhibitor Pefabloc but was unaffected by a wide range of protease inhibitors, including other serine protease inhibitors, such as PMSF (figure 5B). Pefabloc is more stable than PMSF in aqueous solutions and is known to inactivate some serine proteases faster than PMSF does. Pefabloc, but not other protease inhibitors, was also able to inhibit degradation of IL-8 by 4 other S. pyogenes blood isolates. Pefabloc did not adduct to IL-8; analysis by ESI-MS demonstrated that incubation with IL-8 (2:1 molar ratio) for 2 h did not alter the molecular weight of IL-8 (M Av , 8382). Dialysis of Pefabloc-treated culture supernatant did not restore protease activity, which indicates that the inactivation was irreversible.
The protein responsible for IL-8-inactivating activity was purified from H292-TH supernatant by ammonium sulfate precipitation, anion exchange chromatography, and Superose 12 gel filtration as a 120-150-kDa protein ( figure 6A and 6B) . Enzyme purification corresponded to a 4000-fold increase in volume activity, compared with that in crude H292-TH supernatant. The 2 active (IL-8-cleaving) fractions contained SpyCEP (Mascot score, 11200), peptides covered a 154-kDa range from residues 183 to 1571, and SDS-PAGE confirmed the mass. Peptides from this protein were not found in any inactive fractions. The only additional peptides that were common to both active fractions were from UDP-N-acetylglucosamine pyrophosphorylase, glyceraldehyde-3-phosphate dehydrogenase, and a putative tyrosine tRNA ligase, none of which is a proteolytic enzyme. Other peptides were identified, but in only 1 of the active fractions rather than in both; these were from chaperone protein dnaK, triosephosphate isomerase, a putative peroxide resistance protein, and a putative cysteine aminopeptidase C, none of which is predicted to have endopeptidase activity.
Polyclonal antibody raised against SpyCEP peptide recognized 2 different ∼120-150-kDa bands in supernatant from the most potent IL-8-degrading S. pyogenes strains but not from strains that failed to degrade IL-8, which demonstrates that the IL-8-degrading phenotype corresponds to the presence of SpyCEP protein in the supernatant ( figure 6C ).
DISCUSSION
S. pyogenes has evolved an array of mechanisms to combat phagocytosis, including C5a peptidase activity, complement inhibitory activity, and immunoglobulin binding and cleavage strategies [10] [11] [12] . The C-terminal cleavage of IL-8 by S. pyogenes represents an additional major mechanism that may enhance this pathogen's ability to evade the innate immune response. C-terminal cleavage of chemokines is unusual, because most chemokines demonstrate susceptibility to cleavage at the N-terminus. Indeed, endothelial IL-8 is subjected to rapid N-terminal cleavage, which renders it more active [13] . Cleavage of the IL-8 C-terminus by S. pyogenes is predicted to undermine the uptake, transit, and presentation of IL-8 to circulating neutrophils [3] and would prevent the interaction of IL-8 with glycosaminoglycan [14] , an evolutionary strategy not previously demonstrated by other pathogens. Chemically synthesized analogues of IL-8 that lack the C-terminus demonstrate 50-fold reduction in potency of IL-8-induced neutrophil elastase release and chemotaxis; the present work extends those findings in a novel and biologically relevant setting [5] .
The IL-8 59 Q-60 R cleavage site resides within the C-terminal a helix of IL-8. IL-8 can exist as a dimer in solution, and the proposed dimeric structure indicates a role for the C-terminal helix in this association [15, 16] . The oligomerization state of IL-8 necessary for function in vivo is unknown and may depend on local IL-8 concentration at the endothelial surface. Removal of the IL-8 C-terminal helix is likely to disrupt interactions between IL-8 molecules, and future studies will explore whether this precludes formation of the dimer and subsequent biological effects. Interestingly, loss of IL-8 immunoreactivity in ELISA and Western blotting was due to loss of the C-terminus of IL-8, and this suggests that available antibodies to IL-8 bind mostly to this region.
MIP-2, the murine homologue of IL-8, was subject to a single cleavage by S. pyogenes in the analogous position, at 60 Q-61 K, whereas several other Q-K bonds within MIP-2 were preserved. Interestingly, MIP-2 was more resistant to cleavage than IL-8, and this may reflect species-specific preferential cleavage of the Q-R sequence typical of primate but not rodent CXC chemokines. Cleavage of CXC chemokines by S. pyogenes is therefore likely to be dependent on both specific residues and position.
Blood isolates of S. pyogenes demonstrated greater IL-8-cleaving activity than throat isolates, although this distinction was not absolute, and we cannot exclude IL-8-cleaving activity at the bacterial surface. Alteration in virulence of S. pyogenes isolates that have entered the blood is well recognized and may be coordinated by several global regulators [17] . IL-8-cleaving activity could not be attributed to specific emm sequence types, because the IL-8-cleaving phenotype varied between strains of the same emm type (data not shown).
Chemokine degradation by S. pyogenes has been noted by Hidalgo-Grass et al. [18] , although the mechanism by which this occurs and the causative enzyme were not reported. Hidalgo-Grass et al. reported that administration of a peptide (silCR) could attenuate virulence of an M14 S. pyogenes infection in a mouse model and attributed this attenuation to inhibition of MIP-2 degradation. They postulated that the lack of a functional sil locus in certain emm types may confer a virulent phenotype to S. pyogenes, although disruption of the sil locus was reported elsewhere to attenuate virulence of the same M14 strain in mice [19] . The observations reported by Hidalgo-Grass [18] differ from our findings, which show that the IL-8-cleaving phenotype varies within single emm types, that MIP-2 is relatively resistant to cleavage, and that the causative protease is inhibited by Pefabloc only.
Our study showed that SpyCEP is the most likely candidate for the IL-8-cleaving enzyme. Confirmation of the full role that SpyCEP plays in IL-8 cleavage and necrotizing infection will require mutagenesis of a transformable strain, ideally using IL-8 transgenic mice. Western blotting demonstrated that the phenotypic difference between IL-8-degrading isolates and IL-8-nondegrading isolates is closely associated with a difference in detectable levels of SpyCEP. The gene prtS, which encodes SpyCEP, is present in all sequenced S. pyogenes strains but is subject to allelic variation. Studies are underway to determine whether genotypic differences underlie the observed phenotypic variation or whether the differences relate solely to transcriptional/posttranslational regulation.
SpyCEP has a predicted N-terminal signal sequence, 3 subtilisase domains, and a peptidoglycan LPXTG (LPXAG) anchoring motif. SpyCEP is similar to other gram-positive CEPs [20] , C5a peptidase, and subtilisins of Bacillus species. Recombinant expression of SpyCEP is complicated by the size and complexity of its multidomain structure but will enable structure-function analysis. Demonstration of the 130-150-kDa SpyCEP is novel, although a 31-kDa fragment of the same protein was recently identified in an M3 S. pyogenes supernatant [21] . Despite having an LPXAG motif, soluble SpyCEP was released into the supernatant, either through reduced efficiency of the sortase system or through the actions of streptococcal extracellular enzymes. Studies with an M49 speb mutant show that the cysteine protease (SPEB) is unlikely to contribute (data not shown). The precise structure of SpyCEP isoforms detected by Western blotting are unknown, although they were not recognized by antibody to a C-terminus SpyCEP peptide, which confirms that the released SpyCEP is C-terminus truncated.
In summary, S. pyogenes can cleave the C-terminus of human IL-8 at 59 Q-60 R to yield a fragment, IL-8, that lacks the necessary biological activity to promote neutrophil transmigration to infected tissues. This represents a novel and highly specific enzymatic process by which invasive pathogens can evade the human innate immune response and may contribute to the pathogenesis of necrotizing group A streptococcal disease.
